COVTY
Covestro AG
OTC Markets OTCPKUSDEQUITY
Basic Materials
DELAYED
Neutral
-15/100
Last price
33.64
▲ 0.28 (0.84%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
33.36
Day high
33.19
Day low
33.05
Volume
435
Market cap
$14.30B
P/E (TTM)
—
52W range
31.99 – 36.60
Trailing performance
Returnvs SPY
1W
+0.04%
-1.9%
1M
-1.29%
-2.4%
3M
+1.54%
-3.0%
6M
+0.21%
-18.0%
YTD
+0.36%
-13.9%
1Y
-5.00%
-21.4%
3Y
+25.19%
-57.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on COVTY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$14.30B
Enterprise value$15.83B
Revenue (TTM)$12.81B
Gross profit$2.10B
EBITDA$697.00M
Net income$-305.00M
EPS (TTM)$-0.96
Free cash flow$286.50M
Total cash$984.00M
Total debt$2.83B
Book value / share$19.99
Shares outstanding415.28M
Float375.23M
Short % of float—
Dividend yield0.00%
Beta (5Y)0.94
Valuation & profitability ratios
Trailing P/E—
Forward P/E46.98
PEG ratio0.31
Price / sales—
Price / book1.68
EV / revenue1.24
EV / EBITDA22.72
Gross margin16.42%
Operating margin3.63%
Profit margin-2.38%
Return on equity-4.44%
Return on assets0.29%
Debt / equity38.50
Current ratio1.69
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $12.94B | $14.18B | $14.38B | $17.97B | -8.7% |
| Operating revenue | $12.94B | $14.18B | $14.38B | $17.97B | -8.7% |
| Cost of revenue | $11.22B | $12.00B | $12.07B | $15.40B | -6.5% |
| Gross profit | $1.72B | $2.18B | $2.31B | $2.56B | -21.1% |
| Research & development | $342.00M | $392.00M | $374.00M | $361.00M | -12.8% |
| Selling, general & admin | $1.81B | $1.86B | $1.85B | $1.96B | -2.6% |
| Total operating expense | $2.15B | $2.15B | $2.15B | $2.29B | -0.0% |
| Operating income | -$432.00M | $27.00M | $156.00M | $275.00M | -1,700.0% |
| Net interest income | -$131.00M | -$108.00M | -$101.00M | -$113.00M | -21.3% |
| Pre-tax income | -$492.00M | -$27.00M | $73.00M | $130.00M | -1,722.2% |
| Tax provision | $151.00M | $245.00M | $275.00M | $411.00M | -38.4% |
| Net income | -$644.00M | -$266.00M | -$198.00M | -$272.00M | -142.1% |
| Net income to common | -$644.00M | -$266.00M | -$198.00M | -$272.00M | -142.1% |
| Basic EPS | -1.70 | -0.71 | -0.53 | -0.71 | -140.4% |
| Diluted EPS | -1.70 | -0.71 | -0.53 | -0.71 | -140.4% |
| EBIT | -$335.00M | $132.00M | $242.00M | $296.00M | -353.8% |
| EBITDA | $752.00M | $1.12B | $1.14B | $1.65B | -32.6% |
| Basic shares | 379.76M | 377.48M | 378.52M | 381.87M | +0.6% |
| Diluted shares | 379.76M | 377.48M | 378.52M | 381.87M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $648.00M | $509.00M | $625.00M | $1.20B | +27.3% |
| Cash & short-term investments | $767.00M | $518.00M | $638.00M | $1.20B | +48.1% |
| Accounts receivable | $1.50B | $1.75B | $1.90B | $2.01B | -14.1% |
| Inventory | $2.50B | $2.85B | $2.46B | $2.81B | -12.2% |
| Total current assets | $5.91B | $5.77B | $5.89B | $6.67B | +2.4% |
| Property, plant & equipment | $5.60B | $5.90B | $5.79B | $5.80B | -5.1% |
| Goodwill & intangibles | $1.08B | $1.19B | $1.23B | $1.33B | -8.9% |
| Total assets | $13.47B | $13.63B | $13.64B | $14.59B | -1.2% |
| Total current liabilities | $3.87B | $3.58B | $3.30B | $3.06B | +8.1% |
| Current debt | $1.31B | $519.00M | $541.00M | $154.00M | +153.4% |
| Long-term debt | $1.15B | $1.84B | $2.11B | $2.76B | -37.8% |
| Total debt | $3.13B | $3.10B | $3.39B | $3.66B | +1.2% |
| Total liabilities | $6.45B | $6.95B | $7.02B | $7.46B | -7.2% |
| Retained earnings | $1.68B | $2.17B | $2.29B | $2.48B | -22.7% |
| Shareholder equity | $7.00B | $6.66B | $6.59B | $7.09B | +5.1% |
| Working capital | $2.04B | $2.19B | $2.59B | $3.61B | -6.8% |
| Net tangible assets | $5.91B | $5.47B | $5.36B | $5.75B | +8.2% |
| Shares issued | 207.90M | 189.00M | 189.00M | 193.20M | +10.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$643.00M | -$272.00M | -$202.00M | -$281.00M | — | -136.4% |
| Depreciation & amortisation | $1.09B | $984.00M | $894.00M | $1.35B | — | +10.5% |
| Change in working capital | $27.00M | $83.00M | $333.00M | -$106.00M | — | -67.5% |
| Operating cash flow | $487.00M | $870.00M | $997.00M | $970.00M | — | -44.0% |
| Capital expenditure | -$770.00M | -$781.00M | -$765.00M | -$832.00M | — | +1.4% |
| Investing cash flow | -$1.29B | -$423.00M | -$925.00M | -$477.00M | — | -206.1% |
| Share buybacks | — | $0 | -$49.00M | -$150.00M | $0 | — |
| Dividends paid | -$2.00M | -$1.00M | -$4.00M | -$654.00M | — | -100.0% |
| Financing cash flow | $968.00M | -$565.00M | -$639.00M | $64.00M | — | +271.3% |
| Free cash flow | -$283.00M | $89.00M | $232.00M | $138.00M | — | -418.0% |
| End cash position | $648.00M | $509.00M | $625.00M | $1.20B | — | +27.3% |
| Line item | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Total revenue | $2.92B | $3.38B | $3.48B | -13.7% |
| Operating revenue | $2.92B | $3.38B | $3.48B | -13.7% |
| Cost of revenue | $2.70B | $2.83B | $3.01B | -4.4% |
| Gross profit | $212.00M | $552.00M | $465.00M | -61.6% |
| Research & development | $87.00M | $84.00M | $90.00M | +3.6% |
| Selling, general & admin | $445.00M | $449.00M | $477.00M | -0.9% |
| Total operating expense | $621.00M | $503.00M | $562.00M | +23.5% |
| Operating income | -$409.00M | $49.00M | -$97.00M | -934.7% |
| Net interest income | -$27.00M | -$34.00M | -$41.00M | +20.6% |
| Pre-tax income | -$353.00M | $11.00M | -$141.00M | -3,309.1% |
| Tax provision | $24.00M | $70.00M | $20.00M | -65.7% |
| Net income | -$378.00M | -$59.00M | -$160.00M | -540.7% |
| Net income to common | -$378.00M | -$59.00M | -$160.00M | -540.7% |
| Basic EPS | — | -0.16 | -0.43 | — |
| Diluted EPS | — | -0.16 | -0.43 | — |
| EBIT | -$298.00M | $45.00M | -$106.00M | -762.2% |
| EBITDA | $117.00M | $266.00M | $128.00M | -56.0% |
| Basic shares | — | 377.48M | 377.48M | — |
| Diluted shares | — | 377.48M | 377.48M | — |
| Line item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $474.00M | $648.00M | $489.00M | $742.00M | -26.9% |
| Cash & short-term investments | $984.00M | $767.00M | $566.00M | $789.00M | +28.3% |
| Accounts receivable | $1.93B | $1.50B | $1.87B | $1.97B | +28.4% |
| Inventory | $2.73B | $2.50B | $2.65B | $2.92B | +9.0% |
| Total current assets | $6.18B | $5.91B | $5.64B | $6.28B | +4.6% |
| Property, plant & equipment | $5.64B | $5.60B | $5.62B | $5.79B | +0.7% |
| Goodwill & intangibles | $1.08B | $1.08B | $1.14B | $1.17B | +0.1% |
| Total assets | $13.88B | $13.47B | $13.21B | $14.05B | +3.0% |
| Total current liabilities | $3.66B | $3.87B | $4.04B | $4.76B | -5.3% |
| Current debt | — | $1.31B | — | — | — |
| Long-term debt | — | $1.15B | — | — | — |
| Total debt | — | $3.13B | — | — | — |
| Total liabilities | $6.53B | $6.45B | $7.04B | $7.63B | +1.3% |
| Retained earnings | $348.00M | $1.68B | $2.03B | $2.05B | -79.3% |
| Shareholder equity | $7.32B | $7.00B | $6.15B | $6.41B | +4.6% |
| Working capital | $2.52B | $2.04B | $1.59B | $1.52B | +23.3% |
| Net tangible assets | $6.24B | $5.91B | $5.02B | $5.24B | +5.5% |
| Shares issued | 207.64M | 207.90M | 189.00M | 189.00M | -0.1% |
| Line item | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Net income | -$377.00M | -$59.00M | -$161.00M | -539.0% |
| Depreciation & amortisation | $415.00M | $221.00M | $234.00M | +87.8% |
| Change in working capital | $288.00M | -$242.00M | -$175.00M | +219.0% |
| Operating cash flow | $301.00M | -$43.00M | -$73.00M | +800.0% |
| Capital expenditure | -$214.00M | -$185.00M | -$180.00M | -15.7% |
| Investing cash flow | -$825.00M | -$150.00M | -$156.00M | -450.0% |
| Financing cash flow | $572.00M | -$52.00M | $468.00M | +1,200.0% |
| Free cash flow | $87.00M | -$228.00M | -$253.00M | +138.2% |
| End cash position | $648.00M | $489.00M | $742.00M | +32.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $13.84B | +7.0% |
| Next year | — | — | $14.53B | +4.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.00%
Institutions holding3
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
33.73
-0.28% from price
SMA 20
33.96
-0.94% from price
SMA 50
34.25
-1.80% from price
SMA 100
34.07
-1.27% from price
SMA 200
34.37
-2.13% from price
EMA 12
33.75
-0.32% from price
EMA 26
33.98
-1.00% from price
EMA 50
34.09
-1.31% from price
RSI (14)
47.0
Neutral
MACD (12,26,9)
-0.23
Hist -0.06
ATR (14)
0.57
1.71% of price
Realised vol 30D
31.8%
Annualised
Bollinger upper
34.80
20, 2σ
Bollinger lower
33.12
20, 2σ
50 / 200 cross
Death
34.25 vs 34.37
Trend bias
Below 200
-2.13%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.02
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
31.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-8.1%
Peak to trough
Max drawdown 5Y
-59.1%
Peak to trough
ATR 14
0.57
1.71% of price
Beta (reported)
0.94
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 21 | UBS | UPGRADE | Sell | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield3.89%
Payout ratio64.97%
Ex-dividend dateApr 22, 2022
Next pay dateMay 6, 2022
Last split—
Split date—
Headlines
Abu Dhabi’s Oil Giant Inks Partnerships With German Energy, Industry Groups as Part of UAE’s $46.5 Billion Investment
The Wall Street Journal · 26d ago
Medical Plastics Market to Reach USD 48.77 billion by 2031, Growing at a CAGR of 7.0% — MarketsandMarkets™
GlobeNewswire · 50d ago
Following UPM Biochemicals' Commercial Launch at Europe's Largest Biorefinery in Leuna, New Study Maps Growth Trajectory for Bio-Based Bisphenol Replacements
GlobeNewswire · 54d ago
Covestro (DB:1COV) Returned To Profit, Is The Valuation Upside Already Priced In?
Simply Wall St. · 67d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.